ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

AstraZeneca · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
anti-inflammatoryasthma
asthma, severe eosinophilic asthma, anti-inflammatory, reduction period, inhaled corticosteroids, long-acting β2 agonist, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 882548
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.